Login / Signup

Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma.

Kie NakataniSatoshi SeradaMinoru FujimotoKengo ObataTomoharu OhkawaraEri SasabeTetsuya YamamotoTetsuji Naka
Published in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2021)
SOCS1 gene therapy may be a beneficial approach for the treatment of OSCC.
Keyphrases
  • gene therapy
  • stem cells
  • combination therapy
  • bone marrow